| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 7.301 | 78.851 | 233.961 | 608.980 |
| Total Income - EUR | - | - | - | - | - | - | 7.344 | 78.851 | 233.963 | 638.758 |
| Total Expenses - EUR | - | - | - | - | - | - | 13.668 | 99.201 | 187.240 | 573.438 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -6.325 | -20.350 | 46.722 | 65.320 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -6.545 | -22.075 | 44.382 | 51.643 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Dac Medical Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 5.670 | 4.192 | 3.290 | 44.318 |
| Current Assets | - | - | - | - | - | - | 21.398 | 31.868 | 132.077 | 182.014 |
| Inventories | - | - | - | - | - | - | 12.138 | 20.011 | 35.996 | 42.312 |
| Receivables | - | - | - | - | - | - | 4.853 | 4.220 | 51.911 | 94.780 |
| Cash | - | - | - | - | - | - | 4.406 | 7.636 | 44.170 | 44.922 |
| Shareholders Funds | - | - | - | - | - | - | -6.423 | -28.518 | 15.396 | 66.635 |
| Social Capital | - | - | - | - | - | - | 121 | 122 | 121 | 121 |
| Debts | - | - | - | - | - | - | 33.546 | 64.661 | 120.044 | 159.725 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Dac Medical Plus S.r.l.